Kenta Biotech is developing fully human monoclonal antibodies for patients with serious infectious diseases.
Kenta Biotech
Business
Address
Facts from the Community
From the BioVenturist base
Technology Focus:
Investment Round:
| Investment round | Amount raised | Currency | Date | web reference |
|---|---|---|---|---|
|
|
We can also tell you Kenta Biotech is a…
If you know more about Kenta Biotech, you can add more facts here »
